p.122 抽出テキスト

613. 山岸敬幸.生涯先天性心疾患─先天性心疾患の成因・発生から成人期,そして次世代への影響─.日小循誌 2010;26:29-32. 614. Kovacs AH, Moons P. Psychosocial functioning and quality of life in adults with congenital heart disease and heart failure. Heart Fail Clin 2014; 10: 35-42. PMID: 24275293 615. Sillman C, Morin J, Thomet C, et al. Adult congenital heart disease nurse coordination: Essential skills and role in optimizing teambased care a position statement from the International Society for Adult Congenital Heart Disease (ISACHD). Int J Cardiol 2017; 229: 125-131. PMID: 28340978 616. Oster M, Bhatt AB, Zaragoza-Macias E, et al. Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139: e814-e830. PMID: 30586769 617. Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496-502. PMID: 15558755 618. McElhinney DB, Quartermain MD, Kenny D, et al. Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study. Circulation 2016; 133: 1738-1746. PMID: 27002094 619. Kijima Y, Akagi T, Nakagawa K, et al. Cardiac erosion after catheter closure of atrial septal defect: Septal malalignment may be a novel risk factor for erosion. J Cardiol Cases 2014; 9: 134-137. PMID: 30546783 620. Kenny D, Eicken A, Dähnert I, et al. Investigators. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2019; 93: 316-321. PMID: 30719850 621. Kitano M, Yazaki S, Sugiyama H, et al. Risk Factors and Predictors of Cardiac Erosion Discovered from 12 Japanese Patients Who Developed Erosion After Atrial Septal Defect Closure Using Amplatzer Septal Occluder. Pediatr Cardiol 2020; 41: 297-308. PMID: 31732763 622. Abe T, Tsukano S, Tosaka Y. Pericardial tamponade due to erosion of a Figulla Flex II device after closure of an atrial septal defect. Catheter Cardiovasc Interv 2019; 94: 1003-1005. PMID: 31194277 623. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73: 1494-1563. PMID: 30121240 624. Yamaoka H, Takaya Y, Watanabe N, et al. Infective Endocarditis of Patent Foramen Ovale Closure Device Presenting as an Amoeboid-Like Mass. JACC Cardiovasc Interv 2018; 11: 2337-2338. PMID: 30391388 625. Gatzoulis MA, Diller GP, Budts W, et al. The ESC Working Group on Adult Congenital Heart Disease: The Working Group goals to improve the management, quality of life and outcome for the ever increasing number of adults with congenital heart disease are discussed. Eur Heart J 2020; 41: 1870-1871. PMID: 32438404 626. Takaya Y, Akagi T, Kijima Y, et al. Long-term outcome after transcatheter closure of atrial septal defect in older patients: Impact of age at procedure. JACC Cardiovasc Interv 2015; 8: 600-606. PMID: 25907086 627. Nakagawa K, Akagi T, Taniguchi M, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012; 80: 84-90. PMID: 22234992 628. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet 2014; 383: 1921-1932. PMID: 24725467 629. Schoen SP, Kittner T, Bohl S, et al. Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study. Heart 2006; 92: 821-826. PMID: 16284222 630. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Results of the U.S. phase I trial. J Am Coll Cardiol 2006; 47: 319-325. PMID: 16412854 631. Shrestha M, Promphan W, Layangool T, et al. Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices. Catheter Cardiovasc Interv 2019; 93: E30-E37. PMID: 30269417 632. Ogino H, Miki S, Ueda Y, et al. Surgical management of aortic re- gurgitation associated with ventricular septal defect. J Heart Valve Dis 1997; 6: 174-178. PMID: 9130127 633. Tomita H, Arakaki Y, Ono Y, et al. Severity indices of right coronary

cusp prolapse and aortic regurgitation complicating ventricular septal defect in the outlet septum: Which defect should be closed? Circ J 2004; 68: 139-143. PMID: 14745149 634. Tomita H, Arakaki Y, Ono Y, et al. Impact of noncoronary cusp prolapse in addition to right coronary cusp prolapse in patients with a perimembranous ventricular septal defect. Int J Cardiol 2005; 101: 279-283. PMID: 15882676 635. Mongeon FP, Burkhart HM, Ammash NM, et al. Indications and outcomes of surgical closure of ventricular septal defect in adults. JACC Cardiovasc Interv 2010; 3: 290-297. PMID: 20298987 636. Zahn EM, Peck D, Phillips A, et al. Transcatheter Closure of Patent Ductus Arteriosus in Extremely Premature Newborns: Early Results and Midterm Follow-Up. JACC Cardiovasc Interv 2016; 9: 2429-2437. PMID: 27931595 637. Takata H, Higaki T, Sugiyama H, et al. Long-term outcome of coil occlusion in patients with patent ductus arteriosus. Circ J 2011; 75: 407-412. PMID: 21173496 638. Gruenstein DH, Ebeid M, Radtke W, et al. Transcatheter closure of patent ductus arteriosus using the AMPLATZERTM duct occluder II (ADO II). Catheter Cardiovasc Interv 2017; 89: 1118-1128. PMID: 28258658 639. 富田英,高室基樹,堀田智仙.動脈管開存に対するコイル閉鎖術:エキスパートの治療戦略に関するアンケート調査.日小循誌2005;21:660-670. 640. Rao PS. Transcatheter occlusion of patent ductus arteriosus: Which method to use and which ductus to close. Am Heart J 1996; 132: 905-909. PMID: 8831389 641. Lloyd TR, Beekman RH 3rd. Clinically silent patent ductus arteriosus. Am Heart J 1994; 127: 1664-1665. PMID: 8198009 642. Fortescue EB, Lock JE, Galvin T, et al. To close or not to close: The very small patent ductus arteriosus. Congenit Heart Dis 2010; 5: 354-365. PMID: 20653702 643. Eerola A, Jokinen E, Boldt T, et al. The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: A prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides. J Am Coll Cardiol 2006; 47: 1060-1066. PMID: 16516094 644. Jacobs JP, Burke RP, Quintessenza JA, et al. Congenital Heart Surgery Nomenclature and Database Project: atrioventricular canal defect. Ann Thorac Surg 2000; 69 Suppl: S36-S43. PMID: 10798414 645. Mery CM, Zea-Vera R, Chacon-Portillo MA, et al. Contemporary Outcomes After Repair of Isolated and Complex Complete Atrioventricular Septal Defect. Ann Thorac Surg 2018; 106: 1429-1437. PMID: 30009807 646. Anderson RH, Wessels A, Vettukattil JJ. Morphology and morphogenesis of atrioventricular septal defect with common atrioventricular junction. World J Pediatr Congenit Heart Surg 2010; 1: 59-67. PMID: 23804724 647. Rastelli G, Kirklin JW, Titus JL. Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc 1966; 41: 296- 308. PMID: 5932615 648. Fong LS, Betts K, Bell D, et al. Australian CAVSD Study Group. Complete atrioventricular septal defect repair in Australia: Results over 25 years. J Thorac Cardiovasc Surg 2020; 159: 1014-1025.e8. PMID: 31590953 649. Saji T. Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int 2014; 56: 297-303. PMID: 24689825 650. Schwartz SS, Madsen N, Laursen HB, et al. Incidence and Mortality of Adults With Pulmonary Hypertension and Congenital Heart Disease. Am J Cardiol 2018; 121: 1610-1616. PMID: 29655882 651. Drenthen W, Pieper PG, van der Tuuk K, et al. Zahara Investigators. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J 2005; 26: 2581-2587. PMID: 16107486 652. Ginde S, Lam J, Hill GD, et al. Long-term outcomes after surgical repair of complete atrioventricular septal defect. J Thorac Cardiovasc Surg 2015; 150: 369-374. PMID: 26048271 653. Ramgren JJ, Nozohoor S, Zindovic I, et al. Long-term outcome after early repair of complete atrioventricular septal defect in young infants. J Thorac Cardiovasc Surg 2021; 161: 2145-2153. PMID: 32919770 654. Buratto E, McCrossan B, Galati JC, et al. Repair of partial atrioventricular septal defect: a 37-year experience. Eur J Cardiothorac Surg 2015; 47: 796-802. PMID: 25086770 655. Mery CM, Zea-Vera R, Chacon-Portillo MA, et al. Contemporary